Anti-inflammatory pharmaceutical formulations
Patent 6319519 Issued on November 20, 2001. Estimated Expiration Date: 
February 20, 2021. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 20, 2021. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesSustained release, bilayer buoyant dosage form Patent #: 5232704 InventorsAssigneeApplicationNo. 789365 filed on 02/20/2001US Classes:424/472, Layered unitary dosage forms424/464, Tablets, lozenges, or pills424/465, With claimed perfecting feature in contents (e.g., excipient, lubricant, etc.)424/490, Coated (e.g., microcapsules)424/494, Cellulose derivatives424/497, Containing solid synthetic polymers424/499Contains proteins or derivative or polysaccharides or derivativeExaminersPrimary: Page, Thurman K.Assistant: Evans, Charesse Attorney, Agent or FirmForeign Patent References
International ClassA61K 009/24AbstractA pharmaceutical dosage form comprising a tablet containing a non-steroidal anti inflammatory drug and misoprostol, wherein the non-steroidal anti inflammatory drug is in the form of coated pellets.Field of SearchTablets, lozenges, or pillsWith claimed perfecting feature in contents (e.g., excipient, lubricant, etc.) Layered unitary dosage forms Cellulose or derivative Particulate form (e.g., powders, granules, beads, microcapsules, and pellets) Coated (e.g., microcapsules) Cellulose derivatives Ethyl cellulose Containing solid synthetic polymers | |
